Pilleve

Pilleve is a healthcare startup dedicated to preventing prescription opioid abuse and addiction with its innovative solution. Founded in 2017 and headquartered in the United States, Pilleve seeks to address the widespread issue of opioid addiction, which has affected millions of Americans and led to thousands of accidental overdoses. The company's integrated pill bottle and smartphone application form the core of its strategy to ensure the safe and monitored intake of prescription opioids.

Pilleve's approach involves real-time monitoring of a patient's opioid intake, with the system securely holding the opioids and requiring patient authentication through passwords or biometric scans for dispensing. Furthermore, patients are prompted to report their pain levels and mood before intake, allowing for the assessment of aberrant behaviors. This data is collected and analyzed, with physicians receiving real-time alerts if patients exceed recommended dosages. Through their Electronic Health Records (EHRs), physicians can intervene by adjusting prescriptions, limiting dosages, or aiding patients in tapering off medication.

By tackling opioid misuse and abuse, Pilleve not only aims to improve patient outcomes and safety but also decreases the social and financial burden associated with opioid addiction for insurance companies, healthcare providers, and loved ones. The startup's unique approach has attracted the attention of A'Z Angels, who led the Seed Round investment in Pilleve on 16 June 2019.

Overall, Pilleve's innovative and comprehensive solution to opioid abuse presents a promising application of Information Technology in the Healthcare industry, addressing a pressing societal issue while offering potential for substantial returns on investment for interested stakeholders.